Search Results
Moxifloxacin hydrochloride 100 mg | 100.00%
TargetMol
Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.
More Information Supplier PageMoxifloxacin hydrochloride 500 mg | 100.00%
TargetMol
Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.
More Information Supplier PageMoxifloxacin hydrochloride 50 mg | 100.00%
TargetMol
Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.
More Information Supplier PageCanrenone 200 mg | 99.80%
TargetMol
Canrenone is an aldosterone antagonist with potassium-sparing diuretic activity.
More Information Supplier PageCanrenone 50 mg | 99.80%
TargetMol
Canrenone is an aldosterone antagonist with potassium-sparing diuretic activity.
More Information Supplier PagePheniramine maleate 100 mg | Purity Not Available
TargetMol
Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.
More Information Supplier PagePheniramine maleate 500 mg | Purity Not Available
TargetMol
Pheniramine maleate (Trimetose), an alkylamine derivative with antihistaminic and vasodilatory properties, binds to histamine H1 receptors, thereby inhibiting phospholipase A2 and production of the endothelium-derived relaxing factor, nitric oxide.
More Information Supplier PageCilnidipine 50 mg | 100.00%
TargetMol
Cilnidipine(FRC8653) is a dual L- and N-type calcium channel blocker and displays antihypertensive, sympatholytic and neuroprotective activity.
More Information Supplier PageArtemisinin 200 mg | 97.00%
TargetMol
Artemisinin is an ancient Chinese herbal therapy for malarial fevers which has been recently found to have potent activity against many forms of malarial organisms, including chloroquine-resistant Plasmodium falciparum.
More Information Supplier Page
